Blue Owl Capital Holdings »

Ikena Oncology shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Ikena Oncology (IKNA) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Ikena Oncology

Tip: Access up to 7 years of quarterly data

All positions including Ikena Oncology held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ikena Oncology by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.8M 2.0M 1.97

More positions owned by Blue Owl Capital Holdings

Pliant Therapeutics (PLRX)
Robinhood Mkts Com Cl A (HOOD)
Cullinan Oncology (CGEM)
Tourmaline Bio (TRML)
Klaviyo Com Ser A (KVYO)
Owl Rock Capital Corporation (OBDC)
Repare Therapeutics Ord (RPTX)
Acelyrin (SLRN)
Larimar Therapeutics (LRMR)
Keros Therapeutics (KROS)
Ultragenyx Pharmaceutical (RARE)
Engene Holdings (ENGN)
Syros Pharmaceuticals Com New (SYRS)
Disc Medicine (IRON)
E2open Parent Holdings Com Cl A (ETWO)

View all positions for Blue Owl Capital Holdings

Top funds holding Ikena Oncology

Atlas Venture Life Science Advisors
BVF
OrbiMed Advisors
Omega Fund Management
Blue Owl Capital Holdings
Vanguard Group
Artal Group
NEA Management Company
Laurion Capital Management
Barclays
Citadel Advisors
Charles Schwab Investment Management
Bank of New York Mellon
Jacobs Levy Equity Management
Two Sigma Investments

View all funds holding Ikena Oncology